Salivary osteocalcin levels are decreased in smoker chronic periodontitis patients

Oral Diseases

Volumn 17, Issue 2, 2011, Pages 200-205

  Ozcaka O ^a   Nalbantsoy, A ^a   Buduneli, N ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

ICTP; Osteocalcin; Periodontitis; Saliva; Smoking

Indexed keywords

OSTEOCALCIN;

ADULT; AGED; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SALIVA ANALYSIS; SELF REPORT; SMOKING;

ADULT; AGED; CHRONIC PERIODONTITIS; COLLAGEN TYPE I; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SMOKING;

EID: 79951572550     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01721.x     Document Type: Article

References (36)

1. Ah MK, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL (1994). The effect of smoking on the response to periodontal therapy. J Clin Periodontol 21: 91-97.
2. Barbour SE, Nakashima K, Zhang JB et al (1997). Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 8: 437-460.
3. Boström L, Linder LE, Bergström J (1999). Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease. J Clin Periodontol 26: 352-357.
4. Buduneli N, Baylas H, Buduneli E, Türkoǧlu O, Dahlen G (2005a). Evaluation of the relationship between smoking during pregnancy and subgingival microbiota. J Clin Periodontol 32: 68-74.
5. Buduneli N, Buduneli E, Kardeşler L, Lappin D, Kinane DF (2005b). Plasminogen activator system in smokers and non-smokers with and without periodontal disease. J Clin Periodontol 32: 417-424.
6. Buduneli E, Buduneli N, Vardar-Şengül S et al (2005c). Systemic low-dose doxycycline and alendronate administration and serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats. J Periodontol 76: 1927-1933.
7. Buduneli N, Kardeşler L, Işik H et al (2006). Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 33: 159-164.
8. Buduneli N, Biyikoǧlu B, Sherrabeh S, Lappin D (2008). Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol 35: 846-852.
9. Bullon P, Goberna B, Guerrero JM, Segura JJ, Parez-Cano R, Martinez-Sahuguillo A (2005). Serum, saliva and gingival crevicular fluid osteocalcin: their relation to periodontal status and bone mineral density in postmenopausal women. J Periodontol 76: 513-519.
10. Calsina G, Ramon JM, Echeverria JJ (2002). Effects of smoking on periodontal tissues. J Clin Periodontol 29: 771-776.
11. Chapple IL, Mason GI, Garner I et al (1997). Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 34: 412-421.
12. Christenson RH (1997). Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573-593.
13. Edgar WM (1992). Saliva: Its secretion, composition and functions. Br Dent J 172: 305-312.
14. Giannobile WV (1999). C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci 878: 404-412.
15. Giannobile WV, Al-Shammari KF, Sarment DP (2003). Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol 2000 31: 125-134.
16. Gürlek Ö, Lappin DF, Buduneli N (2009). Effects of smoking on salivary C-telopeptide pyridinoline cross-links of type I collagen and osteocalcin levels. Arch Oral Biol 54: 1099-1104.
17. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL (1993). Evidence for cigarette smoking as a major risk factor periodontitis. J Periodontol 64: 16-23.
18. Kaufman E, Lamster I (2000). Analysis of saliva for periodontal diagnosis. J Clin Periodontol 27: 453-465.
19. Kinane DF, Chestnutt IG (2000). Smoking and periodontal disease. Crit Rev Oral Biol Med 11: 356-365.
20. Lamster IB, Kaufman E, Grbic JT, Winston LJ, Singer RE (2003). Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol 74: 353-359.
21. Lappin DF, Eapen B, Robertson D, Young J, Hodge PJ (2009). Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. J Clin Periodontol 36: 634-641.
22. Lian JB, Gundberg CM (1988). Osteocalcin: biochemical considerations and clinical applications. Clin Orthop Relat Res 226: 267-291.
23. Mariotti A (1999). Dental plaque-induced gingival diseases. Ann Periodontol 4: 7-19.
24. Martinez-Canut P, Lorca A, Magan R (1995). Smoking and periodontal disease severity. J Clin Periodontol 22: 743-749.
25. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV (2006). Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 137: 322-329.
26. Narayanan AS, Page RC (1983). Connective tissues of the periodontium: a summary of current work. Coll Relat Res 3: 33-64.
27. Navazesh M (1993). Methods for collecting saliva. Ann N Y Acad Sci 694: 72-77.
28. Oringer RJ, Palys MD, Iranmanesh A et al (1998). C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res 9: 365-373.
29. Oringer RJ, Al-Shammari KF, Aldredge WA et al (2002). ffect of locally delivered minocycline microspheres on markers of bone resorption. J Periodontol 73: 835-842.
30. Palmer RM, Wilson RF, Hasan AS, Scott DA (2005). Mechanisms of action of environmental factor-tobacco smoking. J Clin Periodontol 32: 180-195.
31. Preber H, Bergström J, Linder LE (1992). Occurrence of periopathogens in smoker and non-smoker patients. J Clin Periodontol 19: 667-671.
32. Renvert S, Dahlen G, Wikström M (1998). The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. J Clin Periodontol 25: 153-157.
33. Seibel MJ (2003). Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not? J Endocrinol Invest 26: 464-471.
34. Shi F, Yu S, Xu L (1996). Analysis of serum osteocalcin of patients with periodontitis. Zhonghua Kou Qiang Yi Xue Za Zhi 31: 300-302 (Article in Chinese).
35. Tümer C, Aksoy Y, Güncü GN, Nohutçu RM, Kilinç K, Tözüm TF (2008). Possible impact of inflammatory status on C-telopeptide pyridinoline cross-links of type I collagen and osteocalcin levels around oral implants with peri-implantitis: a controlled clinical trial. J Oral Rehabil 35: 934-939.
36. Yoshihara A, Deguchi T, Hanada N, Miyazaki H (2009). Relation of bone turnover markers to periodontal disease and jaw bone morphology in elderly Japanese subjects. Oral Dis 15: 176-181.